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The clinical and morphological picture of Merkel cell carcino-
ma (MCC) may be rather challenging; therefore, the immuno-
histochemical profile plays a relevant role in confirming the
microscopic diagnosis.A panel of antibodies including cytok-
eratins 20, 7 and epithelial membrane antigen, and neuron-
specific enolase is used in confirming the morphological diag-
nosis of MCC. The majority of MCCs express CK20 and are
CK7-negative.Herein,we present a case of primary cutaneous
neuroendocrine carcinoma with an atypical immunohisto-
chemical pattern. A 83-years old woman presented with a
painless plaque,red to violaceous in colour,located in the leg.
The skin tumor was excided, formalin-fixed and paraffin-
embedded.Tissue sections were immunostained with a panel
of antibodies routinely utilized in complex primary skin tumors
for evidencing epithelial and neuroendocrine differentiation of
tumor cells. The neuroendocrine differentiation of tumor cells
was evidenced by their immunoreactivity for synaptophysin,
chromograninA and neuron-specific enolase.Tumor cells also
showed diffuse cytoplasmic staining for CK7.No immunoreac-
tivity was detected for CK20 and thyroid transcription factor-1.
Our data, together with previous rare reports of CK20-/CK7+
MCCs, lay stress on the importance of routinely utilizing a
panel of antibodies in the differential diagnosis of complex pri-
mary carcinomas of the skin and may have important implica-
tions in expanding the differential diagnosis of  skin tumors. In
particular, caution should be taken in excluding the diagnosis
of MCC only on the basis of the absence of reactivity of tumor
cells for CK20, favouring the wrong diagnosis of  less aggres-
sive skin tumors.
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M
erkel cell carcinoma (MCC), also known
as trabecular carcinoma or primary cuta-
neous neuroendocrine carcinoma, is a
rare and very aggressive skin cancer. MCC is
thought to be derived from pressure-sensing
Merkel cells (Goessling et al., 2002; Schwartz et
al., 2005); it is most commonly found in head and
neck and in the upper extremities of individuals
over 65.The clinical presentation of MCC is non-
specific, presenting as a painless, rapidly growing
(Silva et al., 1984), red to violaceous plaque or
nodule, usually less than 2 cm in diameter. MCC
often recurs locally and has a propensity for both
local and distant metastases via hematogenous
and lymphatic routes. Locoregional recurrence
rates range from 20% to 80% (Tai et al., 2000;
Goessling el al., 2002); metastasis occurs approx-
imately in 50% of cases6, the skin being the main
site of metastatic spread (28%), followed by
lymph nodes (27%), liver (14%) and lung (10%)
(Voog  et al., 1999). The diagnosis of MCC is
based upon the clinical presentation and on the
histological picture, confirmed by immunohisto-
chemical data. Microscopically, MCC appears as a
blue cell tumor with small, round, monomorphic
cells, with scant cytoplasm and a “salt and pep-
per” chromatin pattern.The cells may be arranged
in a variety of patterns including solid, diffuse or
trabecular structures. Defined by both neuroen-
docrine and epithelial differentiation, MCC dis-
plays immunoreactivity for epithelial membrane
antigen (EMA) (Sibley  et al., 1985), neurofila-
ments (Fantini et al., 1995), neuron-pecific eno-
lase (NSE) (Gould et al., 1985), synaptophysin
(Ortonne et al., 1988), chromogranin, neural cell
adhesion molecule (NCAM/CD56) and cytokeratin
(CK) 20 (Moll et al., 1995). Immunohisto-
chemistry is essential in the diagnosis of MCC and
in differentiating it from other tumors including:
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        small cell carcinoma of the lung (SCCL), lym-
phoma, Ewing’s sarcoma and salivary gland small
cell carcinoma. Most MCCs stain positively for
CK20 and are not reactive for CK7 (Jensen et al.,
2000). At  the best of our knowledge, just seven
cases of CK20-negative and CK7 positive MCCs
have been reported (Kenneth et al., 2007). Here
we report a case of this rare variant of primary
neuroendocrine CK20
–/CK7
+ carcinoma.
A 83-years old woman was admitted to our hos-
pital (San Giovanni di Dio, Cagliari) for a pain-
less, red to violaceous plaque, located in the leg.
There was no previous history of irradiation. A
wide excision of the lesion, including grossly free
margins, was performed.
The lesion measured 5 mm in its greatest diam-
eter and extended in depth up to 8 mm.
Microscopically,the tumor was superficially locat-
ed but not connected to the epidermis.It showed a
trabecular dermal population of epithelioid cells
with enlarged nuclei characterized by a “salt and
pepper” chromatin pattern (Figure 1a), and a
brisk mitotic rate, in the absence of  necrosis.
Neuroendocrine differentiation was evidenced by
immunoreactivity of tumor cells for synapto-
physin, chromograninA and NSE (Figure 1b). In
addition, cancer cells showed diffuse cytoplasmic
staining for CK7 (Figure 1c). CK20 (Figure 1d)
and TTF-1 staining were negative. Clinical work
up for metastatic disease including CT scan of the
thorax was negative. No evidence of metastatic
disease was present at a 6 months follow up.
Primary cutaneous neuroendocrine carcinoma
was initially described as a distinct entity by Toker
in 1982 (Toker,1982).Thirty seven years later,the
origin and histogenesis of MCC remains contro-
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Figure 1. Merkel cell carcinoma: (a) MCC showing nests of deeply basophilic proliferating cells within the papillary and reticular der-
mis. (hematoxylin and eosin; 4x, original magnification); (b) a ribbon-like (trabecular) growth pattern cells positive for NSE (25x, orig-
inal magnification); (c) cells diffusely positive for Ck7 (25x, original magnification); (d) absent immunoreactivity for Ck 20 (25x, orig-
inal magnification).277
versial. Suggested origins of MCC include sweat
gland epithelium,Merkel cell and pluripotent cells
in the epidermis and/or dermis (Brwon et al.,
2000). The description of granules in MCC has
been described as indistinguishable from those
seen in cells of neural crest derivation, suggesting
the origin of MCC from Merkel cells (Silva et al.,
1984). Merkel cells are known to be CK20-posi-
tive;only in a subset of MCC CK7 immunoreactiv-
ity has also been described (Yao et al., 2002).The
diagnosis of MCC can be both clinically and histo-
logically challenging. The clinical presentation is
rather non-specific and lesions initially interpreted
as basal cell carcinoma or squamous cell carcino-
ma (SCC) can be later diagnosed as MCC, based
upon the immunohistochemical findings. Immuno-
histochemistry focused upon both the epithelial
and neuroendocrine differentiation of MCC, has
now become essential in confirming the diagnosis
of this tumor. CK20 positivity and CK7 negativity
is considered the typical immunohistochemical
profile useful in confirming the diagnosis of MCC.
CK20 is an intermediate filament protein whose
expression is primarily restricted to gastric and
intestinal epithelium (Botta et al., 2001), urothe-
lium, taste buds of the tongue and Merkel cells
(Moll and Franke,1985;Moll et al., 1995).CK20
staining in MCC is described as having a charac-
teristic perinuclear punctuate staining pattern.
Cutaneous SCC, basal cell carcinoma and
melanoma have been shown to be negative for
CK20 (Moll and Franke, 1985). Bobos et al.
reported that CK20 was expressed in  87% of
MCCs (339/391), while in SCCL CK20
immunoreactivity was showed only in 14 of 302
cases (4.6%) (Bobos et al., 2006).
Our case showed a peculiar immunohistochemi-
cal profile: synaptophysin, chromogranin, NSE
positivity, CK20 negativity and immunoreactivity
for CK7. CK7, a member of the basic type II CKs,
is mainly found in glandular epithelia and in tran-
sitional epithelia (Kenneth et al., 2007). CK7 has
been reported to be expessed in association with
CK20 in 23-31% of MCCs (Bobos et al., 2006).
In a review of the literature, there are document-
ed cases of CK20+/CK7+, CK20+/CK7-CK20-
/CK7- MCCs (Jensen et al., 2000). Only seven
cases, at the best of our knowledge, with the
CK20-/CK7+ profile have been described
(Kenneth  et al., 2007). The significance of the
immunophenotype CK20-/CK7+ in a primary neu-
roendocrine carcinoma is yet to be determined.
Merkel cells are known to be CK20
+ and in a
review of the literature CK7 immunoreactivity has
also been described in a  subset of Merkel cells
(Yao et al., 2002).
The absence of reactivity for CK20 and the
aberrant expression of CK7, absent in normal
Merkel cells,could identify a subset of MCCs orig-
inating from dedifferentiated Merkel cells.
According to Kenneth et al. (2007), the findings
of positive CK7 staining in MCC carcinoma may
further define/expand the immunohistochemical
profile of this neoplasm while supporting a possi-
ble derivation from Merkel cells. Finally, from a
practical point of view, our case underlines that
caution should be taken in excluding the diagnosis
of MCC only on the basis of the absence of
immunoreactivity for CK20, favoring the wrong
diagnosis of less aggressive skin tumors.
References
Bobos M, Hytiroglou P, Kostopoulos I, Karkavelas G, Papadimitriou
CS. Immunohistochemical distinction between Merkel cell carcino-
ma and small cell carcinoma of the lung. Am J Dermatopathol
2006;28: 99-104.
Botta MC,Ambu R,Liguori C,Van Eyken P,Pisanu A,Cabras A,et al.
CK20 expression in the gastrointestinal tract of the embryo and
fetus. Pathologica 2001;93:640-4.
Brwon HA, Sawyer DM,Woo T. Intraepidermal Merkel cell carcinoma
with no dermal involvement. Am J Dermatopathol 2000;22: 65-9.
Fantini F, Johansson O. Neurochemical markers in human cutaneous
Merkel cells.An immunohistochemical investigation. Exp Dermatol
1995;4:365-71.
Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin
Oncol 2002;20:588-98.
Gould VE, Moll R, Moll I, Lee I, Franke WW. Biology of disease.
Neuroendocrine (Merkel) cells of the skin: hyperplasias, dysplasias,
and neoplasms. Lab Invest 1985;52:334-53.
Jensen K, Kholer S, Rouse RV. Cytokeratin staining in Merkel cell car-
cinoma: an immunohistochemical study of Cytokeratins 5/6, 7, 17
and 20. Appl Immunohistochem Mol Morphol 2000;8:310-5.
Calder KB, Coplowitz S, Schlauder S, Morgan MB. A case series and
immunophenotypic analysis of CK20-/CK7+ primary neuroen-
docrine carcinoma of the skin. J Cutan Pathol 2007;34:918-23-
Moll I, Kuhn C, Moll R. Cytokeratin 20 is a general marker of cuta-
neous Merkel cells while certain neuronal proteins are absent. J
Invest Dermatol 1995;104:910-5.
Moll R,Franke WW.Cytoskeletal differences between human neuroen-
docrine tumors: a cytoskeletal protein of molecular weight 46,000
distinguishes cutaneous from pulmonary neuroendocrine neoplasms.
Differentiation 1985;30:165-75.
Ortonne JP, Petchot-Bacque JP, Verrando P, Pisani A, Pautrat G,
Bernerd F. Normal Merkel cells express a synaptophysin-like
immunoreactivity. Dermatologica 1988;177:1-10.
Sibley RK, Dahl D. Primary neuroendocrine (Merkel cell?) carcinoma
of the skin. II. An immunocytochemical study of 21 cases. Am J
Surg Pathol 1985;9:109-16.
Schwartz RA,Lambert WC.The Merkel cell carcinoma:a 50-year ret-
rospect. J Surg Oncol 2005;89:5.
Sidhu GS, Feiner H, Flotte TJ, Mullins JD, Schaefler K, Schultenover
Letter to the editor278
SJ. Merkel cell neoplasms. Am J Dermatopathol 1980;2:101-9.
Silva EG, Mackay B, Goepfert H, Burgess MA, Fields RS. Endocrine
carcinoma of the skin (Merkel cell carcinoma). Pathol Annu
1984;19:1-30.
Tai PT, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, et al.
Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin:
case series and review of 204 cases. J Clin Oncol 2000;18:2493-9.
Toker C. Trabecular carcinoma of the skin. Am J Dermatopathol
1982;4:497-500.
Voog E, Biron P, Martin JP, Blay JY. Chemotherapy for patients with
locally advanced or metastatic Merkel cell carcinoma. Cancer
1999;85:2589-95.
Yao DX, Hoda SA, Chiu A,Ying L, Rosen PP. Intraepidermal cytoker-
atin 7 immunoreactive cells in the non-neoplastic nipple may repre-
sent interepithelial extension of lactiferous duct cells.
Histopathology 2002;40:230-6.
L. Pilloni et al.